Cargando…
Incorporating DNA Sequencing into Current Prenatal Screening Practice for Down's Syndrome
BACKGROUND: Prenatal screening for Down's syndrome is performed using biochemical and ultrasound markers measured in early pregnancy such as the Integrated test using first and second trimester markers. Recently, DNA sequencing methods have been introduced on free DNA in maternal plasma, yieldi...
Autores principales: | Wald, Nicholas J., Bestwick, Jonathan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604109/ https://www.ncbi.nlm.nih.gov/pubmed/23527014 http://dx.doi.org/10.1371/journal.pone.0058732 |
Ejemplares similares
-
Prenatal maternal plasma DNA screening for cystic fibrosis: A computer modelling study of screening performance
por: Old, Robert W., et al.
Publicado: (2017) -
Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13
por: Bestwick, Jonathan Paul, et al.
Publicado: (2019) -
Improvements in antenatal screening for Down's syndrome
por: Wald, N J, et al.
Publicado: (2013) -
Distribution of nuchal translucency in antenatal screening for Down's syndrome
por: Bestwick, J P, et al.
Publicado: (2010) -
Antenatal Screening for Down Syndrome Using Serum Placental Growth Factor with the Combined, Quadruple, Serum Integrated and Integrated Tests
por: Wald, Nicholas J., et al.
Publicado: (2012)